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Abstract
Background: In mammalian cells changes in intracellular pH (pHi), which are predominantly
controlled by activity of plasma membrane ion exchangers, regulate a diverse range of normal and
pathological cellular processes. How changes in pHi affect distinct cellular processes has primarily
been determined by evaluating protein activities and we know little about how pHi regulates gene
expression.
Results: A global profile of genes regulated in mammalian fibroblasts by decreased pHi induced by
impaired activity of the plasma membrane Na-H exchanger NHE1 was characterized by using
cDNA microarrays. Analysis of selected genes by quantitative RT-PCR, TaqMan, and immunoblot
analyses confirmed results obtained from cDNA arrays. Consistent with established roles of pHi
and NHE1 activity in cell proliferation and oncogenic transformation, grouping regulated genes into
functional categories and biological pathways indicated a predominant number of genes with altered
expression were associated with growth factor signaling, oncogenesis, and cell cycle progression.
Conclusion: A comprehensive analysis of genes selectively regulated by pHi provides insight on
candidate targets that might mediate established effects of pHi on a number of normal and
pathological cell functions.
Background
Intracellular pH (pHi) homeostasis is exquisitely control-
led. Variations in pHi both reflect and determine changes
in a number of cellular processes, including adhesion,
proliferation, metabolism, and programmed cell death.
How pHi responds to and regulates distinct cellular proc-
esses has primarily been determined by evaluating protein
activities. Although effects of pHi on gene expression have
been determined in yeast [1] and bacteria [2], we know lit-
tle about how pHi regulates gene expression in metazoan
cells.
In metazoan cells pHi homeostasis is maintained by a
number of H+ translocating mechanisms, primarily local-
ized at the plasma membrane. In mammalian fibroblasts,
a predominant regulator of pHi is the Na-H exchanger,
NHE1. NHE1 is an H+ extruder, catalyzing an electroneu-
tral exchange of extracellular Na+ for intracellular H+ and
regulating pHi and cell volume homeostasis. NHE1 activ-
ity is increased in response to growth factors and onco-
genes [3,4], and increases in NHE1 activity and pHi
promote cell cycle progression [5], increased proliferation
[6,7], and cell survival [8]. NHE1 activity is necessary for
a number of cytoskeleton-associated processes including
cell shape determination [6], remodeling of cell-substrate
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adhesion complexes [6,9,10], and directed cell migration
[9,11,12]. NHE1-dependent increases in pHi also play an
essential role in cell transformation and the development
of malignant progression [13,14] and NHE1-deficient
cells have a markedly reduced capacity for tumor growth
in vivo [15].
In this study we used cDNA microarray analysis to deter-
mine changes in steady-state gene expression in fibrob-
lasts stably a mutant NHE1 lacking ion translocation
activity compared with fibroblasts stably expressing wild-
type NHE1. Consistent with a role for NHE1 in cell
growth regulation, the unbiased microarray analysis indi-
cated that in the absence of NHE1 activity there are signif-
icant changes in the expression pattern of genes related to
growth factor signaling, growth and oncogenesis, and
DNA synthesis and cell cycle control.
Results and Discussion
Global gene profiling
Recent evidence indicates that in addition to the function
of NHE1 in ion translocation and pHi homeostasis, the
exchanger also acts as a scaffold to assemble signaling
complexes and as a plasma membrane anchor for the
actin-based cytoskeleton [3,6]. To selectively impair only
ion translocation by NHE1, we engineered an ion translo-
cation-defective NHE1 containing an isoleucine substitu-
tion for glutamine 266 (NHE1-E266I). In cells expressing
NHE1-E266I, the scaffolding and actin anchoring func-
tions of NHE1 are retained, but ion translocation is absent
[5,6]. Wild-type NHE1 (LAPN cells) and NHE1-E266I
(LAPE cells) were stably expressed in NHE1-null LAP1
cells, which are derived from NHE1-expressing Ltk-mouse
muscle fibroblasts [16,17]. As previously reported [5]
NHE1 expression in LAPN and LAPE cells, as determined
by immunoblotting, is similar and steady-state pHi in the
continuous presence of serum and HCO3
- is ~7.35 for
LAPN cells and ~7.10 for LAPE cells. The presence of
HCO3
- allowed the function of anion exchangers contrib-
uting to pHi homeostasis in the absence of ion transloca-
tion by NHE1.
For DNA microarray analysis, significant regulation of
genes in LAPE cells compared with LAPN cells was defined
as a fold change > 1.5 with a p value of < 0.05 from five
independent cell preparations and microarray hybridiza-
tions. Of the 6,500 probe sets, 198 or 3.05% were signifi-
cantly different in LAPE cells. Two widely used approaches
to analyze DNA microarray data include hierarchial clus-
tering of genes with similar expression patterns [18] and
grouping of biologically related genes into processes or
pathways [19,20]. We used the latter strategy to group
genes regulated by NHE1 activity into related biological
pathways or processes. Genes were grouped according to
key-words representing functional categories and Gen-
MAPP, developed by the Conklin laboratory at the Uni-
versity of California, San Francisco [20,21], was used to
visualize gene expression data on maps representing bio-
logical pathways. The advantage of a pathway-based anal-
ysis is that it provides a global perspective of functionally-
related genes. Pathway-based grouping indicated a sub-
stantial number of differentially expressed genes associ-
ated with growth factor/hormone signaling and growth
and oncogenesis (Fig. 1). The caveat of pathway-based
analyses is that based on key-word representation, some
genes are implicated in multiple biological processes.
Hence, we listed all genes exhibiting significant changes in
LAPE cells compared with LAPN cells (Table 1). Data in
Table 1 are grouped according to biological function with
absolute changes indicated.
Growth factor and oncogenic signaling
The expression of a substantial number of genes encoding
proteins related to growth factor/hormone signaling and
growth and oncogenesis was altered in LAPE cells com-
pared with LAPN cells. A schematic cascade of growth fac-
tor signaling indicates that a number of genes regulated in
LAPE cells function in Ras-dependent signaling (Fig 2A).
Activation of many of these signaling proteins, including
serotonin (5HT) [22] and thrombin (PAR2) [23] recep-
tors, Ras [13], Raf [24], PLCγ1 [25], and Erk [26,27] stim-
ulates NHE1 activity. Increased NHE1 activity and a
resulting intracellular alkalinization are thought to be
necessary for oncogenic transformation [14] and tumor
development [15]. Immunoblot analysis confirmed
increased protein expression of Fyn, PLCγ1, and ERK2 in
LAPE cells compared with LAPN cells (Fig. 2B), In LAPE
cells, the global increased expression of a number of genes
involved in growth factor and oncogenic signaling sug-
gests a feedback response to acidic or osmotic stress. Alter-
natively, because the proliferative response is suppressed
in LAPE cells [5] (Fig. 3), increased growth factor signaling
could result from a feedback mechanism to maintain cell
proliferation.
Expression of a number of transcription factor genes act-
ing downstream of growth factor signaling was also differ-
entially regulated in LAPE cells compared with LAPN cells
(Fig. 2A). Fra1 and Fra2 are Fos proteins and components
of the AP1 transcription factor. They form dimmers with
Jun transcription factors to regulate a number of cell proc-
esses including differentiation, proliferation, and onco-
genic transformation [28]. The regulated expression of
two members of the C/EBP (CAAT/enhancer binding pro-
tein) family of transcription factors was confirmed. RT-
PCR was used to confirm decreased expression of C/EBPδ
(Fig. 2C), which dimerizes with C/EBPβ in response to
Ras-ERK signaling to regulate adipocyte [29,30] and epi-
dermal [31] differentiation. Increased expression of
GADD153 (CHOP), which is a transcription factor in theBMC Genomics 2004, 5:46 http://www.biomedcentral.com/1471-2164/5/46
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C/EBP family, was confirmed by TaqMan analysis (Fig.
2D). GADD153 dimerizes with other C/EBP isomers to
inhibit their binding to C/EBP binding sites in the pro-
moters of a number of genes involved in differentiation
and mitogenesis [32,33]. Expression of GADD153
increases in response to DNA damage [34], and oxidative
stress [35,36], hence its role in cell cycle progression is
also included in Figure 3.
Relative functional clustering of genes differentially regulated in LAPE cells Figure 1
Relative functional clustering of genes differentially regulated in LAPE cells. Percentage of genes in the indicated 
functional categories that were regulated (A), had increased expression (B), and decreased expression in LAPE cells compared 
with LAPN cells (p < 0.05, n = 5).BMC Genomics 2004, 5:46 http://www.biomedcentral.com/1471-2164/5/46
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Table 1: Differential Gene Expression in LAPE Cells Relative to 
LAPN Cells
Growth Factor/Hormone Signaling Accession fold-change
phospholipase C gamma 1 W65065 4.1
uPAR X62701 3.5
MDK1 (neuronal tyrosine kinase 
receptor)
X79082 3.2
FGF-6 M92416 3.1
TC21 ras-like protein W91283 3.1
tyrosine kinase SEK receptor precursor W53668 3.0
GC Binding Protein Z36270 3.0
FGFR-4 X59927 2.9
casein kinase II alpha AA153726 2.8
FYN tyrosine protein kinase W35964 2.6
ERK2 W51403 2.5
PIP5KII P48426 2.5
P2X purinoceptor 3 (ATP receptor) AA050453 2.3
IRG47 GTP binding-protein M63630 2.3
p120GAP P09851 2.2
PDGF/VEGF member X99572 2.1
FGF-4 X14849 2.0
CAP adenylyl cyclase-associated protein L12367 2.0
N-ras X13664 1.9
protein-tyrosine phosphatase epsilon 
precursor
U35368 1.7
guanine nucleotide binding protein G(K) 
alpha
W64628 1.6
brain-derived neurotrophic factor X55573 1.6
Grg1 groucho-related gene 1 protein U61362 1.5
SOS 2 (ras GEF) Z11664 1.5
proteinase activated receptor 2, PAR2 Z48043 -1.8
receptor of activated protein kinase C 
(RACK1)
AA024231 -1.8
PAK p21-activated kinase AA117286 -2.0
guanine nucleotide binding protein 
gamma-7
W64628 -2.1
ERF1 EGF-response factor 1 W33538 -2.3
Fgd1 (faciogenital dysplasis) (Cdc42 
GEF)
U22325 -2.7
5-HT5B serotonin receptor X69867 -2.7
chemokine receptor type 4 P70658 -2.7
A-raf AA104043 -3.4
FGF-7 Z22703 -3.5
GRK5 W36620 -3.7
Emr1 receptor (EGF-7 TM family) U66890 -4.3
gliostatin (PD-ECGF) AA008687 -5.9
MAPKK 3 W29331 -8.2
Growth and Oncogenesis Accession fold-change
semaphorin E X85994 5.0
Evi-1 proto-oncogene X54989 3.1
interferon-inducible protein 9–27 P13164 2.5
testis-specific c-abl protein J02995 2.5
MAF proto-oncogene W77346 2.3
MUC18 melanoma-associated antigen AA088962 2.3
B94 TNF-α-induced early response gene L24118 2.1
calpactin I light chain M16465 2.1
Fra 1 U34245 2.0
cell division protein FTSH homolog AA014057 1.9
ALL-1 zinc finger protein HRX W62585 1.9
LAF-4 lymphoid nuclear protein U34361 1.7
calpactin I heavy chain D10024 1.6
insulin-induced growth response protein 
CL-6
AA030483 1.5
mage-like protein W51344 -1.9
TRAF4 X92346 -2.1
rearranged mutant c-myb gene M13990 -2.1
Ing1 AF177757 -2.2
Fra 2 P15408 -2.8
ERV1 AA034842 -2.9
MAGE-11 W51344 -3.4
MCF2 Dbl proto-oncogene W98059 -4.0
HSP 90 alpha AA117183 -9.1
membrane glycoprotein Z22552 -10.7
Cell Cycle/DNA Replication Accession fold-change
GADD153 X67083 45.7
wee1 kinase D30743 2.3
RAD54 DNA-repair gene X97796 1.9
14-3-3 protein tau/theta W61758 1.7
G1/S-specific cyclin D1 P25322 1.7
cell division-associated protein BIMB. AA165880 -1.5
proliferating-cell nuclear antigen AA088121 -1.7
CKS-2 cyclin-dep kinases regulatory 
subunit 2
X54942 -1.8
GADD45 AA138777 -2.1
gas1 X65128 -2.5
SKCDC25 Q02342 -4.1
FLAP endonuclease-1; FEN-1 AA072149 -7.5
Cytoskeleton Accession fold-change
clip 170 (restin) W13214 4.2
septin 2 (NEDD5 PROTEIN) W51490 3.6
KIF4 kinesin-like protein AA109999 3.4
neuraxin AA048974 2.1
kinesin light chain 1 W81858 2.1
axonemal dynein heavy chain Z83815 1.9
septin 4 (BRAIN PROTEIN H5) AA020101 1.8
gelsolin J04953 1.7
myosin regulatory light chain 2, smooth 
muscle isoform
W18383 -4.5
NF2 neurofibromatosis type 2 isoform I X74671 -5.7
Cell Adhesion and Extracellular 
matrix
Accession fold-change
mast cell protease 5 precursor AA032912 6.3
osteopontin X51834 2.3
neural cell adhesion molecule (NCAM-
140)
X07233 2.1
anti-von Willebrand factor antibody 
NMC-4 kappa chain
U90238 2.1
inter-alpha-inhibitor H2 X70392 2.0
galectin-3 P16110 1.8
extensin precursor W75015 1.7
E-selectin ligand-1 (ESL-1) X84037 -1.6
microfibril associated glycoprotein 
precursor (MAGP)
W08049 -1.8
integrin beta-5 subunit precursor W14823 -2.0
lectin lambda U56734 -3.3
type IV collagenase Z27231 -26.0
Ion Transporters Accession fold-change
CMP-sialic acid transporter Z71268 2.5
V-ATPase A U13837 2.2
AKR voltage-gated potassium-channel 
(KCNA4)
U03723 2.1
potassium channel protein NGK2 Y07521 2.0
Table 1: Differential Gene Expression in LAPE Cells Relative to 
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glucose transporter type 4 insulin-
responsive (GT2)
M23383 -4.0
synaptic vesicle amine transporter AA166512 -7.1
V-ATPase E W50167 -10.4
Transcriptional Regulation Accession fold-change
histone H3.1 X16496 6.2
retinoic acid-binding protein X51715 3.7
HNF-3/Forkhead homolog II Q61575 3.2
transcription regulatory protein MCP-1 
(POU 1)
D13801 3.0
NfiA2-protein (nuclear factor 1) Y07691 1.8
transcription factor C1 U53925 -1.5
GATA-6 U51335 -1.6
zinc finger protein 91 Q05481 -1.9
winged-helix gene, htlf Y12656 -2.2
C/EBP delta X61800 -2.5
retinoid X receptor-beta X66224 -2.9
HLX homeo box protein X58250 -3.8
Nucleotide Processing Accession fold-change
myoblast cell surface antigen W98426 5.6
activator 1 37 KD subunit W85565 3.6
RNA polymerase II large subunit M12130 3.0
DNA-directed RNA polymerase III 
largest subunit
W54015 3.0
uridylate kinase AA114781 1.8
U1RNA-associated 70-kDa protein X15769 -1.6
U6 snRNA-associated protein W34985 -3.3
Protein Processing Accession fold-change
eukaryotic peptide chain releasing factor 
GTP-binding subunit
AA105072 2.5
putative ATP-dependent RNA helicase 
PL10
AA125293 2.4
40S ribosomal protein S10 W13807 2.1
tryptophanyl-tRNA synthetase AA051240 1.8
ubiquitin carboxyl-terminal hydrolase 
(protease 4)
W50538 1.6
ribosomal protein L32 K02060 -1.8
elongation factor TS (forms complex 
with EF-tu)
W70475 -1.9
ubiquitin carboxyl-terminal hydrolase 
(protease 8)
AA087408 -2.4
elongation factor 2 (EF-2) P05086 -2.6
phenylalanine – tRNA synthetase AA020069 -3.8
threonyl-tRNA synthetase AA051240 -4.5
elongation factor TU AA088054 -5.4
Stress-related Accession fold-change
glutathione peroxidase AA038094 2.9
thioredoxin-dependent peroxide 
reductase 2
W85659 1.6
superoxide dismutase 3 (SOD3) X84940 -1.5
thioredoxin-dependent peroxide 
reductase 1
W88176 -2.1
glutathione S-transferase, GSTT1 X98055 -3.2
24p3 lipocalin X81627 -23.7
Carbohydrate Metabolism Accession fold-change
pyruvate kinase M2 AA168931 3.8
hexokinase P24049 2.4
phosphofructose kinase-2 P70265 2.3
acetyl-Coenzyme A acetyltransferase 2 BC000408 -1.8
Ldh-2 X51905 -1.9
ERV1 AA034842 -2.9
galactokinase 2 AA145750 -2.9
Table 1: Differential Gene Expression in LAPE Cells Relative to 
LAPN Cells (Continued)
citrate transport protein AA108822 -2.9
phosphorylase B kinase gamma catalytic 
subunit
AA015461 -3.7
fructose-1,6-bisphosphatase P19112 -4.0
lactate dehydrogenase P00338 -4.0
Electron Transport and Oxidative 
Phosphorylation
Accession fold-change
ATP synthase (subunit D) P31399 6.4
NADH-ubiquinone oxidoreductase 
(complex I)
BC002772 2.3
cytochrome C oxidase VIa U08439 2.2
ATP synthase P1precursor (subunit C) W16250 2.0
ATP synthase (subunit A) W49135 1.8
mitochondrial inner membrane protease 
subunit 1
AA009014 -1.5
cytochrome P450IIIA D26137 -3.9
Trafficking Accession fold-change
beta adaptin P21851 1.9
rab10 AA119194 1.5
rab8 P22128 3.3
rab11b L26528 -1.5
BRAIN PROTEIN I47(similar to yeast 
SEC 17)
W55684 -1.7
PROTEIN TRANSPORT PROTEIN 
SEC22
AA023107 -1.8
SYNAPTOBREVIN 2 AA072236 -4.6
Immune-related Signaling Accession fold-change
anti-DNA immunoglobulin heavy chain 
IgG
U55461 3.5
immunoglobulin rearranged kappa chain ET62056 3.4
complement receptor type 2 precursor 
(CR2)
W98124 2.6
thymocyte B cell antigen precursor AA068606 2.3
immunoglobulin alpha heavy chain J00475 2.2
interferon gamma receptor second 
chain
U69599 1.8
pre-B cell enhancing factor precursor W59723 1.8
interferon beta type 2 V00756 1.7
anti-DNA immunoglobulin light chain 
IgG
U55604 1.6
FK506-binding protein precursor 
(FKBP-13)
AA163272 -1.5
immunoglobulin light chain Fv-fragment Y10941 -2.3
Ig 1B4.B5 heavy chain mRNA for mouse 
cytochrome c
ET61726 -2.3
immunoglobulin-like receptor PIRA1 U96682 -2.8
CD10 neutral endopeptidase (pre-B cell 
differentiation)
M81591 -3.1
immunoglobulin variable region, heavy 
chain
X95878 -3.3
immune-responsive gene 1 (Irg1) L38281 -3.9
anti-DNA immunoglobulin heavy chain 
IgG
U55550 -4.1
immunoglobulin light chain variable 
region
ET61272 -7.8
immunoglobulin heavy chain variable 
region
ET62261 -8.2
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Cell cycle regulation
NHE1 activity has a permissive effect in promoting cell
proliferation [6,7] and cDNA microarray analysis
indicated a number of genes with roles in DNA synthesis
and cell cycle control had altered expression in LAPE cells
compared with LAPN cells. We recently reported [5] that
the proliferative rate of LAPE cells is ~3 to 4-fold less than
that of LAPN cells and that LAPE cells lack a pH-depend-
ent timing of cell cycle progression that is specifically
associated with delayed G2/M entry and transition. Con-
sistent with these findings there was an upregulation of
genes associated with G2/M arrest and DNA repair
responses (Fig. 3A). Decreased protein expression of
GADD45 and FEN1 was confirmed by immunoblotting
(Fig. 3B,3C). The decrease in FEN1 in LAPE cells was most
marked when cells were synchronized by a double thymi-
dine block, and released from the block for 3 to 9 hours
(Fig. 3C). GADD45, which acts in DNA repair, is generally
upregulated with cell cycle arrest [37,38], and FEN1 is
thought to play an essential role in DNA replication and
in base excision repair [39,40]. Although decreased
expression of GADD45 and FEN1 in LAPE cells appears
paradoxical, recent findings indicate that a decrease in
GADD45 would contribute to p53 instability [38] and
FEN1 is stimulated by proliferating nuclear antigen [41],
which is decreased in LAPE cell (Fig. 3A). Additional
growth arrest and DNA damage-inducible proteins,
including Rad54 and GADD153, were upregulated.
Rad54 functions in homologous recombination repair
pathways to maintain telomere length [42] and it facilities
chromatin remodeling [43], which correlates with
increased histone H3 in LAPE cells (Fig. 2). As described
above, increased GADD153 expression, which was con-
firmed TaqMan analysis (Fig. 5B), is induced by growth
arrest, DNA damage, and environmental stress. Despite an
established role for GADD153 in inducing apoptosis
[44,45], and its increased expression in LAPE cells (~45-
fold), there was no indication that LAPE cells have
increased necrosis or apoptosis compared with LAPN
cells.
Consistent with LAPE cells having delayed G2/M entry
and progression [5], the array analysis indicated upregula-
tion of genes negatively regulating G2/M, including 14-3-
3  θ and Wee1 kinase. Increased expression of Wee1
kinase, which induces inhibitory phosphorylation of
Cdc2 on tyrosine 15 [46], was confirmed by TaqMan anal-
ysis (Fig. 3D). Moreover, there was a downregulation of
genes associated with promoting cell cycle progression,
including CDC25 (Fig 3A) and CKS-2 (Fig. 3A), and
involved in chromatin assembly, including histone H3
(Fig. 2A). Although cDNA array analysis of asynchronous
LAPE cells did not indicate a change in cyclin B1 expres-
sion, we found that with a time-dependent release of cells
from a double thymidine block, cyclin B1, as indicated by
immunoblotting, was significantly downregulated in
LAPE cells compared with LAPN cells (Fig. 3C). Hence,
loss of NHE1 activity likely decreases the stability of cyclin
B1 protein rather than decreasing cyclin B1 gene expres-
sion. Decreased cyclin B1 expression and increased Wee1
kinase expression is consistent with our previous finding
that Cdc2 kinase activity is inhibited in LAPE cells com-
pared with LAPN cells [5].
Carbohydrate metabolism, electron transport and 
oxidative phosphorylation
A global pattern of metabolic genes differentially regu-
lated in LAPE cells would favor glycolysis and oxidative
phosphorylation, possibly in response to reduced ATP
(Fig. 4A). Paradoxically, expression of genes encoding
enzymes that regulate substrate entry for glycolysis was
decreased. Decreased expression of the glucose trans-
porter Glut-4 was confirmed by TaqMan analysis (Fig 4B).
Additionally, decreased phosphorylase kinase would
favor decreased conformational change of phosphorylase
b to phosphorylase a, and reduced glycogen breakdown to
glucose 6-phosphate and decreased galactokinase would
favor decreased utilization of galactose for glycolysis. Key
regulators of glycolytic flux, however, including hexoki-
nase, phosphofusctose kinase, and pyruvate kinase were
upregulated in LAPE cells compared with LAPN cells.
Increases in hexokinase and phosphofusctose kinase,
which catalyze the first and second ATP ultilization steps
of glycolysis, respectively, and in pyruvate kinase, which
catalyzes the final reaction of glycolysis, would favor
increased production of pyruvate. Phosphorylation of
fructose 6-phosphate by phosphofusctose kinase is a rate-
determining reaction and the activity of phosphofusctose
kinase is stimulated by low AMP and inhibited by high
ATP and by citrate. In LAPE cells, a decrease in citrate
transport protein would likely decrease cytosolic citrate, a
negative regulator of phosphofusctose kinase, and indi-
rectly increase phosphofusctose kinase activity. Glycolytic
Miscellaneous Accession fold-change
parotid secretory protein X01697 4.0
amyloid-like protein 1 precursor Q03157 4.0
liver receptor homologous protein M81385 1.7
oncomodulin Z48238 -1.6
tctex-1 M25825 -1.6
beta-hydroxysteroid dehydrogenase 
type 2
X90647 -2.8
C57BL/6J ob/ob haptoglobin M96827 -2.9
angiotensin-converting enzyme J04947 -3.2
Swiss Webster demilune cell-specific 
salivary gland protein
W15826 -7.1
neurexophilin 1 U56651 -7.8
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Genes differentially regulated in LAPE cells grouped as functioning in growth factor signaling and transcriptional regulation Figure 2
Genes differentially regulated in LAPE cells grouped as functioning in growth factor signaling and transcrip-
tional regulation. A. Schematic diagram of growth factor signaling and transcriptional regulation. Red indicates genes with 
increased expression in LAPE cells compared with LAPN cells, and blue indicates genes with decreased expression. B. Immuno-
blot analysis of the indicated proteins confirmed increased protein expression in LAPE cells predicted by GeneChip data. C. 
Relative RT-PCR for the transcription factor C/EBP delta confirmed GeneChip data of increased expression in LAPE cells com-
pared with LAPN cells. D. TaqMan analysis confirmed increased expression of GADD153 in LAPE cells compared with LAPN 
cells. Data in A represent the means of fold-increase or – decrease in LAPE cells (p < 0.05, n = 5). Data in B, C, and D are rep-
resentative of 2 to 3 separate cell preparations.BMC Genomics 2004, 5:46 http://www.biomedcentral.com/1471-2164/5/46
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Genes differentially regulated in LAPE cells grouped as functioning in the G2/M transition of cell cycle progression and DNA  damage checkpoint Figure 3
Genes differentially regulated in LAPE cells grouped as functioning in the G2/M transition of cell cycle progres-
sion and DNA damage checkpoint. A. Schematic diagram of G2/M regulation. Red indicates genes with increased expres-
sion in LAPE cells compared with LAPN cells, and blue indicates genes with decreased expression. B. Immunoblot of GADD45 
confirmed decreased protein expression in LAPE cells compared with LAPN cells. C. Immunblotting for FEN1 and cyclin B1 at 
the indicated times after release from a double thymidine block. C. Relative TaqMan expression of Wee1 kinase confirmed 
GeneChip data of increased Wee1 expression in LAPE cells compared with LAPN cells. Data in A represent the means of fold-
increase or – decrease in LAPE cells (p < 0.05, n = 5). Data in B and C are representative of 2 to 3 separate cell preparations. 
Data in D represent the mean ± s.e.m. of 3 separate cell preparations.BMC Genomics 2004, 5:46 http://www.biomedcentral.com/1471-2164/5/46
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flux and NADH would also be favored by decreased
expression of fructose 1,6-bis-phosphate, which limits
substrate recycling, and lactate dehydrogenase, which
catalyzes the reduction of NADH by pyruvate to yield
NAD+ and lactate. An established metabolic difference in
oncogenic transformed cells compared with normal cells
Genes differentially regulated in LAPE cells grouped as functioning in glycolysis, electron transport and oxidative  phosphorylation Figure 4
Genes differentially regulated in LAPE cells grouped as functioning in glycolysis, electron transport and oxida-
tive phosphorylation. A. Schematic diagram of carbohydrate metabolism and oxidative phosphorylation. Red indicates genes 
with increased expression in LAPE cells compared with LAPN cells, and blue indicates genes with decreased expression. B. Rel-
ative TaqMan expression of Glut-4 confirmed GeneChip data of decreased Glut-4 expression in LAPE cells compared with 
LAPN cells. Data in A represent the means of fold-increase or – decrease in LAPE cells (p < 0.05, n = 5). Data in B are repre-
sentative of 2 separate cell preparations.BMC Genomics 2004, 5:46 http://www.biomedcentral.com/1471-2164/5/46
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is increased lactic acid production [47] and decreased lac-
tate dehydrogenase in LAPE cells correlates with increased
NHE1 activity being necessary for oncogenic transforma-
tion [14] and tumor development [15].
Consistent with increased glycolysis and pyruvate produc-
tion in LAPE cells, key enzymes favoring ATP production
by electron transport and oxidative phosphorylation were
increased (Fig. 4A). Increases in NADH-ubiquinone oxi-
doreductase and cytochrome c oxidase would favor oxida-
tion of NADH. Increases in subunits A, C, and D of ATP
synthase would increase endergonic synthesis of ATP. ATP
synthase in the inner mitochondrial membrane is a pro-
ton translocator, extruding protons into the mitochon-
drial matrix. Whether decreased cytosolic pH in LAPE cells
compared with LAPN cells alters the pH of the mitochon-
drial matrix and proton-electromotive force powering
ATP synthesis remains to be determined. Collectively, the
profile of gene expression in LAPE cells suggests equilib-
rium towards increased glycolytic flux and ATP
production.
Cytoskeleton and extracellular matrix
cDNA array analysis indicated that loss of NHE1 activity
in LAPE cells was associated with the regulation of a
number of genes involved in cytoskeleton organization,
cell adhesion, and extracellular matrix assembly. The reg-
ulation of several genes correlates with reported effects of
NHE1 activity and pHi on cell shape determination [6],
cell polarity [9], actin-filament bundling [9,48], cell-sub-
strate adhesion [9,10] and cell migration and metastasis
[9,11,14]. NHE1 acts as an anchor for actin filaments by
binding directly members of the ERM (ezrin, radixin,
moesin) family of actin binding proteins, and in LAPE
cells, expression of NF2 (merlin), a tumor suppressor pro-
tein and member of the ERM family, was downregulated.
Consistent with a role for NHE1 activity in cell polarity
and actin dynamics, loss of NHE1 activity was associated
with decreased expression of myosin regulatory light
chain, and increased expression of gelsolin (Fig. 5A), a
pH-dependent actin severing and capping protein.
Although regulation of the microtubule-based cytoskele-
ton by NHE1 and pHi have previously not been reported,
a number of microtubule-related genes, including Clip
170, KIF4, kinesin light chain, and a dynein heavy chain,
were upregulated in LAPE cells.
Consistent with NHE1-dependent cell adhesion and
migration, LAPE cells had a marked (~26-fold) decrease in
type IV collagenase (MMP-9) expression, and
zymography confirmed that activity of MMP-9, but not
activity of MMP-4, was selectively decreased in LAPE cells
compared with LAPN cells (Fig. 5B). Correlating with a
decrease in MMP-9 expression, LAPE cells also had similar
marked (~24-fold) decrease in the expression of lipocalin
24p3, which was confirmed by TaqMan analysis (Fig. 5C).
NGAL (Neutrophil Gelatinase Associated Lipocalin), the
human homolog of mouse lipocalin, is covalently bound
to MMP-9 and protects MMP-9 from degradation [49,50].
Lipocalins are transcriptionally regulated by C/EBPβ [51],
which is likely suppressed by decreased expression of C/
EBPδ (Fig. 2C) and increased expression of GADD153
(Fig. 2D). Moreover, increased expression of MMP-9 [52]
and lipocalins [53] is associated with tumor cell growth
and invasion, which correlates with a role for NHE1 activ-
ity in these processes [14,15].
Conclusions
In summary, global profiling revealed genes regulated by
loss of NHE1 activity and decreased pHi. A number of the
differentially regulated genes involved in growth factor
signaling, cell cycle progression, and cytoskeleton and
extracellular matrix remodeling are consistent with previ-
ously established roles of NHE1 activity and pHi  in
mitogenic responses, cell proliferation, and tumor metas-
tasis and invasion. In contrast, some genes, including
those regulating carbohydrate metabolism and
microtubule dynamics, have previously not been linked
to NHE1 activity. An important future direction is to
determine primary and secondary effects of gene regula-
tion by NHE1 and of particular interest is whether
promoters within the genes differentially regulated in
LAPE cells are pH-responsive.
Expression of cytoskeleton and extracellular matrix genes  differentially regulated in LAPE cells Figure 5
Expression of cytoskeleton and extracellular matrix 
genes differentially regulated in LAPE cells. A. Immu-
noblotting for gelsolin (top panel) and zymography for type 
IV collagenase (MMP-9) activity (bottom panel) confirmed 
increases and decreases, respectively, in LAPE cells com-
pared with LAPN cells observed with GeneChip data. B. Rel-
ative TaqMan analysis indicated decreased p24p3 expression 
in LAPE cells, consistent with GeneChip data.BMC Genomics 2004, 5:46 http://www.biomedcentral.com/1471-2164/5/46
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Methods
Cell culture and RNA preparation
The generation of LAPN and LAPE cells was as previously
described [5]. In brief, NHE1-null LAP1 cells developed
from parental Ltk-mouse muscle fibroblasts [16] were
used for stable expression of wild-type NHE1 (LAPN cells)
or expression of NHE1-E266I containing a single point
substitution of glutamate266 for isoleucine that results in
complete loss of ion translocation activity (LAPE) [5,6].
Cells were maintained in DMEM supplemented with 10%
FCS in the presence of 25 mM NaHCO3 and 5% CO2.
Total RNA was prepared from cells plated for 48 h by
using Qiagen's RNeasy® midi kit.RNA. RNA was collected
from five independent cell platings and used for five sep-
arate DNA array hybridizations.
cDNA synthesis and microarray hybridization
Total RNA was converted to double-stranded cDNA using
the SuperScript Choice system (Gibco BRL), except that
HPLC-purified T7-(dT)24 oliomer (5'-GGCCAGTGAATT-
GTAATACGACTCACTATAGGGAGGCGG – (dT)24) was
used instead of the oligo (dT) or random primers pro-
vided with the SuperScript Choice kit. Double-stranded
cDNA was collected by ethanol precipitation. Biotinylated
cRNA was then generated from the cDNA by an in vitro
transcription (IVT) reaction using the ENZO BioArray™
HighYield™ RNA Transcript Labeling Kit. IVT products
(cRNA) were collected by using Qiagen's RNeasyR mini
kit, then ethanol-precipitated and quantitated. The cRNA
was fragmented by alkaline treatment and hybridized to a
GeneChip probe array from Affymetrix (Santa Clara, CA).
The Affymetrix murine oligonucleotide array
(Mu11KSubB) is complementary to ~6,500 murine genes
and expressed sequence tags (ESTs). Each gene or EST is
represented on the array by 16 – 20 feature pairs. Each fea-
ture pair contains a 25-bp oligonucleotide sequence,
which is either a perfect match to the gene or a single cen-
tral-base hommomeric mismatch control.
Microarray hybridization analysis
Affymetrix GeneChip analysis was performed using stand-
ard procedures [54]. The expression level of any particular
transcript was calculated by subtracting he difference
between the fluorescence intensities of the perfect match
and mismatch feature pairs and then averaging over the
entire probe set (Avg Diff). The Avg Diff value for each
transcript was averaged over the five experiments for
LAPN and LAPE cells; these average values obtained from
five independent hybridizations were then used to calcu-
late fold changes in LAPE cells relative to LAPN cells for
each transcript. We did not use comparison algorithms
supplied with the Affymetrix software.
Immunoblot analysis
Proteins from total cell lysates were separated by SDS-
PAGE as previously described [5] and transferred to PVD
nitrocellulose membranes for immunoblotting. Antibod-
ies for immunoblotting included Fyn (NeoMarkers),
PLCγ-1 and Erk 1–2 (Cell Signaling), GADD45, FEN1,
and cyclin B1 (Santa Cruz Biotechnology), and actin
(Sigma).
TaqMan™ analysis
Confirmation of GeneChip data was accomplished using
TaqMan™ chemistry with the ABI 7700 Prism real-time
PCR instrument (ABI, Foster City CA). Custom primers
specific to the genes of interest were synthesized by Life
Technologies and TaqMan™ probes for each gene were
synthesized by Integrated DNA Technologies, Inc. The for-
ward and reverse primers for mouse GADD153 (GenBank
accession no. X67083) were 5'-GAAACGAAGAGGAA-
GAATCAAAAAC-3' and 5'-ATCTGGAGAGCGAG-
GGCTTT-3', respectively, and the probe was 5'-FAM/
ACCCTGCGTCCCTAGCTTGGCTGAC/TAM-3', corre-
sponding to an amplicon of 122 bp. The forward and
reverse primers for mouse Wee1 kinase (GenBank
accession no. NM_009516) were 5'-TTGCTCTTGCTCT-
CACAGTCGT-3' and 5'-TGGGAAAGCACTTGTGGGAT-3',
respectively, and the probe was 5'-FAM/CCTTCCCA-
GAAATGGAGAGCACTGGC/TAM-3', corresponding to an
amplicon of 118 bp. The forward and reverse primers for
mouse Glut4 (GenBank accession no. NM_009204) were
5'-TGGCCATCTTCTCTGTGGGT-3' and 5'-ATTGGCTAG-
GCCCATGAGG-3', respectively, and the probe was 5'-
FAM/TATGCTGGCCAACAATGTCTTGGCC/TAM-3', cor-
responding to an amplicon of 138 bp. The forward and
reverse primers for mouse 24p3 (GenBank accession no.
W13166) were 5'-GGCAGCTTTACGATGTACAGCA-3'
and 5'-TCTGATCCAGTAGCGACAGCC-3', respectively,
and the probe was 5'-FAM/CATCCTGGTCAGGGACCAG-
GACCAG/TAM-3', corresponding to an amplicon of 111
bp. For each gene, PCR was conducted in triplicate with
50 µl reaction volumes of 1x PCR buffer A (Applied Bio-
systems, Foster City, CA), 2.5 mM MgCl2, 0.4 µM each
primer, 200 µM each dNTP, 100 nM probe and 0.025 u/
µl Taq Gold (ABI, Foster City CA). For each experiment, a
large master mix of the above components was made and
aliquoted into each optical reaction tube. Each primer/
probe set (5 – 10 µl) was then added, and PCR conducted
using the following cycle parameters: 95°C 12 min × 1
cycle, (95°C 20 sec, 60°C 1 min) × 40 cycles. Data analy-
sis was carried out using sequence detection software that
calculates the threshold cycle (Ct) for each reaction which
is used to quantitate the amount of starting template in
the reaction. A difference in Ct values (∆Ct) was calculated
for each gene by taking triplicate Ct values from three reac-
tions and subtracting the mean Ct of the triplicates for the
control gene, GAPDH, for each cDNA sample at the sameBMC Genomics 2004, 5:46 http://www.biomedcentral.com/1471-2164/5/46
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concentration. An additional difference in Ct values (∆Ct)
was calculated for each gene by taking the triplicate ∆Ct
values for each gene in the mutant LAPN1-E266I cells and
subtracting the mean ∆Ct of the triplicates for the wild-
type LAPN cells. The relative expression levels were calcu-
lated as = 2 -∆∆Ct [55].
Quantitative RT-PCR analysis
Relative quantitative RT-PCR was preformed using Quan-
tumRNA™ 18S internal standards from Ambion, Inc.
(Austin TX) that included 18S Primers and Competim-
ers™. By optimizing the assay and choosing an
appropriate18S Primer:Competimer ratio for each sam-
ple, the 18S signal was reduced to the same linear range as
that identified empirically for the gene specific product.
The amplicon for the 18S primers was 315 bp. Custom
primers specific to the genes of interest were synthesized
by Life Technologies. The forward and reverse primers for
calpactin I light chain (GenBank accession no. M16465)
were 5'-GTGGACAAAATAATGAAGGAC-3' and 3'-ACAA-
GAAGCAGTGGGGCAGAT-5', respectively, correspond-
ing to an amplicon of 222 bp. The forward and reverse
primers for CEBPδ (GenBank accession no.
NM_007679.1) were 5'-ATACCTCAGACCCCGACAGCG-
3' and 3'-CAAAAGTCTGTCGGAAATGTC-5', respectively,
corresponding to an amplicon of 220 bp. Total RNA was
isolated from LAPN1 and LAPN1-E266I cells in four sep-
arate experiments, using Qiagen's RNeasy® midi kit.
Reverse transcription of total RNA from each sample was
carried out using random decamers and the RETROscript™
kit from Ambion. RT reactions were then subjected to PCR
using the gene specific primers above (final concentration
of 0.4 uM each), the appropriate 18S
Primer:Competimer ratio and 10uCi/ul [α-32P]dCTP for
labeling. PCR was conducted using the following cycle
parameters: (94°C 30 sec, 57°C 30 sec, 72°C 30 sec) × 21
cycles for CEBPδ and 19 cycles for calpactin I light chain.
Empirically derived 18S Primer:Competimer ratios were
1:18 for CEBPδ and 2:8 for calpactin I light chain.
Zymography
Activity of type IV collagenase (MMP9) was determined
by zymography, as previously described [56].
Abbreviations
Ezrin, radixin, moesin (ERM); Intracellular pH (pHi), Na-
H exchanger type 1 (NHE1); NGAL (Neutrophil Gelati-
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